Achelios Therapeutics
Pre-clinicalAchelios Therapeutics’ primary focus is the development of “New Therapeutic Entities” (NTE) for the treatment of pain and inflammation by topically delivered medications.
Founded
2016
Focus
Small Molecules
About
Achelios Therapeutics’ primary focus is the development of “New Therapeutic Entities” (NTE) for the treatment of pain and inflammation by topically delivered medications.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationDurham, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile